⚙
Encounter Mode Selection
Why This Matters
Telepsychiatry and in-person evaluations have different documentation requirements. Telehealth requires documentation of patient location, provider location, platform used, and verbal consent to telehealth services. In-person requires physical proximity attestation and may include physical exam elements.
Telepsychiatry Header
// Insert at top of note
ENCOUNTER TYPE: Telepsychiatry — Initial Psychiatric Evaluation
DATE: [DATE] | TIME: [START TIME] – [END TIME]
PLATFORM: [Doxy.me / Zoom for Healthcare / Epic MyChart Video / Other]
PATIENT LOCATION: [City, State — patient confirmed home address]
PROVIDER LOCATION: [Clinic Name, City, State]
MODALITY: Synchronous audio-video (two-way interactive)
CONSENT TO TELEHEALTH: Patient verbally confirmed understanding of telehealth
services, privacy limitations, and right to receive in-person care.
Consent obtained and documented.
TECHNICAL QUALITY: Audio: [Clear/Intermittent] Video: [Clear/Intermittent/Audio-Only]
IDENTITY VERIFIED: [Date of birth / Photo ID shown on camera]
EMERGENCY PROTOCOL REVIEWED: Patient confirmed local ER: [Hospital Name].
Crisis line reviewed: 988 Suicide & Crisis Lifeline.
In-Person Header
// Insert at top of note
ENCOUNTER TYPE: In-Person — Initial Psychiatric Evaluation
DATE: [DATE] | TIME: [START TIME] – [END TIME]
LOCATION: [Clinic Name, Address]
ACCOMPANYING PERSON: [Name, relationship — or "Patient seen alone"]
PATIENT VERIFIED: [Photo ID reviewed / Date of birth confirmed]
VITALS (if obtained): BP: [___] | HR: [___] | Wt: [___] | BMI: [___] | SpO2: [___]
1
Demographics & Referral
Patient Demographics
PATIENT: [Full Name]
DOB: [MM/DD/YYYY] | AGE: [##] | SEX: [M/F/Other]
GENDER IDENTITY: [as reported] | PRONOUNS: [he/him / she/her / they/them]
PREFERRED NAME: [if different]
MRN: [___________]
REFERRAL SOURCE: [Self / PCP / Therapist / ER / Insurance / Other: _____]
REFERRING PROVIDER: [Name, credentials, practice]
PRIMARY CARE PROVIDER: [Name, phone, fax]
THERAPIST/COUNSELOR: [Name, phone — or "None identified"]
INSURANCE: [Payer, plan, ID#]
LEGAL STATUS: [Voluntary / Involuntary / Guardian — specify]
INTERPRETER NEEDED: [No / Yes: Language _____, Mode: Phone/Video/In-person]
2
Chief Complaint & History of Present Illness
Why Document This Way
The HPI must establish medical necessity. Onset, duration, severity, associated symptoms, and functional impairment are the pillars of complexity that justify the level of service billed. "Patient presents with depression" is insufficient. Quantify everything possible.
Chief Complaint
CHIEF COMPLAINT: [Patient's own words in quotes]
// Example: "I've been depressed for months and my doctor said I should see a psychiatrist."
History of Present Illness
HISTORY OF PRESENT ILLNESS:
[Patient Name] is a [age]-year-old [gender] with [no/a] prior psychiatric history, presenting
for initial psychiatric evaluation with chief complaint of [CC].
ONSET: Symptoms began approximately [timeframe] ago. [Acute vs. gradual onset].
Precipitating factors: [life stressor / medical event / medication change / unknown].
COURSE: [Episodic / Persistent / Progressive / Fluctuating].
[Best period in past month]. [Worst period].
SEVERITY: Patient rates current [mood/anxiety/etc.] as [#]/10.
[PHQ-9 score: ## — severity level]. [GAD-7 score: ## — severity level].
ASSOCIATED SYMPTOMS:
Neurovegetative: [Sleep: ↑/↓/normal | Appetite: ↑/↓/normal | Energy: ↑/↓/normal]
Cognitive: [Concentration: impaired/intact | Memory: concerns/intact]
Psychomotor: [Agitation / Retardation / Normal]
Hedonic: [Anhedonia present/absent]
Somatic: [Headaches / GI / Pain / Other]
FUNCTIONAL IMPACT:
Work/School: [Unable to work / Decreased productivity / Missing ## days/month]
Relationships: [Conflict / Withdrawal / Stable]
Self-care: [Intact / Impaired — describe]
ADLs: [Independent / Requires assistance]
TREATMENT TO DATE:
Prior medication trials: [See Past Psychiatric History]
Current medications for psychiatric symptoms: [List or "None"]
Current therapy: [Yes: type, frequency / No]
Patient's response to prior treatment: [described in past psych hx]
PATIENT'S GOALS FOR TREATMENT: "[Patient's own words]"
3
Psychiatric Review of Systems
Why Screen All Domains
A complete psychiatric ROS protects you legally and clinically. Missed bipolar disorder, undetected psychosis, or undisclosed PTSD can derail treatment and expose you to liability. Document what you asked, what was endorsed, and what was denied.
Psychiatric Review of Systems
PSYCHIATRIC REVIEW OF SYSTEMS:
[ MOOD ]
Depressed mood: [+/-] Duration: [___]
Anhedonia: [+/-]
Hopelessness: [+/-]
Worthlessness/guilt: [+/-]
Elevated/euphoric mood: [+/-] // Screen for mania — see below
Irritability: [+/-]
Mood lability: [+/-]
[ ANXIETY ]
Excessive worry (GAD): [+/-] About: [___]
Panic attacks: [+/-] Frequency: [___] Last episode: [___]
Social anxiety: [+/-]
Specific phobias: [+/-] Specify: [___]
OCD symptoms: [+/-] Obsessions: [___] / Compulsions: [___]
Health anxiety: [+/-]
[ MANIA / HYPOMANIA ]
Decreased need for sleep: [+/-]
Grandiosity: [+/-]
Racing thoughts: [+/-]
Pressured speech: [+/-]
Increased goal-directed activity: [+/-]
Impulsivity/risk-taking: [+/-]
Hypersexuality: [+/-]
Duration of episodes: [___]
// If any positive: assess for Bipolar I vs II vs cyclothymia
[ PSYCHOSIS ]
Auditory hallucinations: [+/-] Content: [___] Frequency: [___]
Visual hallucinations: [+/-]
Other hallucinations: [+/-] Specify: [___]
Delusions: [+/-] Type: [paranoid/grandiose/somatic/other]
Ideas of reference: [+/-]
Thought disorganization: [+/-]
Derealization: [+/-]
Depersonalization: [+/-]
[ TRAUMA / PTSD ]
History of trauma: [+/-] Type: [combat/abuse/accident/other] — patient's words
Intrusive memories/flashbacks: [+/-]
Nightmares: [+/-]
Avoidance: [+/-]
Hypervigilance: [+/-]
Emotional numbing: [+/-]
PC-PTSD-5 score: [___/5] // Positive ≥3
[ SUBSTANCE USE ]
See Section 5 — Substance Use History (separate detailed assessment)
[ EATING ]
Restriction/fasting: [+/-]
Binge eating: [+/-]
Purging behaviors: [+/-]
Body image disturbance: [+/-]
Current weight concerns: [+/-]
[ COGNITIVE ]
Memory complaints: [+/-]
Word-finding difficulty: [+/-]
Executive function: [+/-]
Concentration: [+/-]
MoCA/MMSE (if assessed): [___]
[ SLEEP ]
Insomnia (onset/maintenance/terminal): [+/-]
Hypersomnia: [+/-]
Sleep apnea (dx'd or suspected): [+/-]
Nightmares: [+/-]
Parasomnias: [+/-]
[ SOMATIC ]
Unexplained physical symptoms: [+/-]
Pain (chronic): [+/-] Location: [___]
GI symptoms: [+/-]
Fatigue: [+/-]
[ SELF-HARM / SUICIDALITY ]
// Detailed assessment in Risk Section — document brief screen here
Current SI: [+/-]
History of attempts: [+/-]
Current NSSI: [+/-]
4
Past Psychiatric History
Why Document Prior Medication Trials
Documenting prior medication trials with specific responses establishes the clinical reasoning for your current choices. Payers require this for prior authorizations. Legally, it shows you considered alternatives. Clinically, it informs your prescribing decisions.
Past Psychiatric History
PAST PSYCHIATRIC HISTORY:
PRIOR DIAGNOSES: [List with approximate date of diagnosis]
PSYCHIATRIC HOSPITALIZATIONS:
[None / List: Hospital, Date, Duration, Reason, Voluntary/Involuntary, Discharge Rx]
ER VISITS (psychiatric):
[None / List: Date, Reason, Outcome]
PARTIAL HOSPITALIZATION / IOP:
[None / Program name, dates, completion status]
OUTPATIENT TREATMENT HISTORY:
[Prior psychiatrists/NPs: Names, approx. dates, reason for discontinuation]
[Prior therapists: Names, modality, approx. dates]
SUICIDE ATTEMPTS:
[None / List each:]
Date: [___] Method: [___] Medical severity: [ER/ICU/none]
Precipitant: [___] Lethality: [low/moderate/high] Intent at time: [___]
SELF-HARM (non-suicidal):
[None / Type: ___, Frequency: ___, Last occurrence: ___, Currently active: Y/N]
PRIOR MEDICATION TRIALS:
// List ALL psychiatric medications — this protects you clinically and legally
Drug | Dose | Duration | Reason Stopped | Response
--------------|------------|------------|---------------------|------------------
[Medication] | [dose] | [duration] | [SE/ineffective/cost] | [helpful/not/partial]
[Medication] | [dose] | [duration] | [reason] | [response]
[Medication] | [dose] | [duration] | [reason] | [response]
CURRENT PSYCHIATRIC MEDICATIONS (from prior provider):
[List or "None"]
PSYCHOTHERAPY HISTORY:
[CBT / DBT / EMDR / Psychodynamic / Supportive / Other]
Response: [helpful/partially helpful/not engaged]
5
Substance Use History
Why Screen Systematically
Substance use affects psychiatric diagnosis (substance-induced vs. independent disorders), medication choices (interactions, contraindications), and safety planning. CAGE-AID and AUDIT-C are validated, brief, and defensible in the medical record.
Substance Use Assessment
SUBSTANCE USE HISTORY:
[ ALCOHOL ]
Current use: [None / Social / Regular — ## drinks/week]
Pattern: [Daily / Weekends / Binge (≥4W/≥5M per occasion)]
AUDIT-C Score: [___/12] // ≥3W/≥4M = positive screen
Q1 (frequency): [0-4] Q2 (drinks/day): [0-4] Q3 (heavy drinking days): [0-4]
CAGE-AID: [___/4] // ≥2 = clinically significant
Cut down: [Y/N] Annoyed: [Y/N] Guilty: [Y/N] Eye-opener: [Y/N]
Last drink: [___] Blackouts: [Y/N]
Withdrawal hx: [Seizures: Y/N | DTs: Y/N | CIWA required: Y/N]
Prior treatment: [AA / Detox / MAT — specify]
[ CANNABIS ]
Current use: [None / Y — frequency: ___, form: ___, potency: ___]
Age of first use: [___] Method: [smoked/vaped/edibles]
Last use: [___] Perceived benefit: [pain/sleep/anxiety/mood/other]
[ STIMULANTS ]
Cocaine/crack: [None / Y — frequency: ___, route: ___, last use: ___]
Amphetamines (illicit): [None / Y — frequency: ___, last use: ___]
Methamphetamine: [None / Y]
[ OPIOIDS ]
Prescription opioids (non-prescribed): [None / Y — drug: ___, freq: ___]
Heroin: [None / Y — route: ___, last use: ___]
Fentanyl (illicit): [None / Y]
Overdose history: [None / Y — date(s), required naloxone: Y/N]
Current MAT: [Buprenorphine / Methadone / Naltrexone — provider: ___]
[ BENZODIAZEPINES / SEDATIVES ]
Prescribed: [None / Y — drug: ___, dose: ___, prescriber: ___]
Non-prescribed: [None / Y — source: ___, frequency: ___]
[ TOBACCO / NICOTINE ]
Current: [Never / Former (quit ___) / Current — PPD: ___, years: ___]
NRT/cessation: [Y — product: ___ / N]
[ OTHER ]
Hallucinogens: [None / Y — substance: ___, last use: ___]
Dissociatives (ketamine, PCP): [None / Y]
Inhalants: [None / Y]
Other: [___]
SUBSTANCE USE DISORDER DIAGNOSES: [List or "None identified at this time"]
IN RECOVERY: [N/A / Y — duration: ___, supports: ___]
NALOXONE: [Prescribed: Y/N | Patient has access: Y/N | Education provided: Y/N]
6
Medical History, Surgical History & Allergies
Medical / Surgical / Allergies
PAST MEDICAL HISTORY:
[Condition 1 — year diagnosed, current treatment]
[Condition 2]
[None reported / See PCP records]
PAST SURGICAL HISTORY:
[Procedure — year]
[None]
CURRENT MEDICATIONS (all):
Drug | Dose | Frequency | Prescriber | Indication
--------------------|-----------|-----------|-------------------|------------
[Medication] | [dose] | [freq] | [provider] | [reason]
[Medication] | [dose] | [freq] | [provider] | [reason]
OTC/Supplements: [List]
ALLERGIES / ADVERSE REACTIONS:
Drug: [Name] — Reaction: [___] — Severity: [mild/moderate/severe/anaphylaxis]
NKDA (no known drug allergies) / NKA
RELEVANT LABS (recent, if available):
CMP: [date / values] CBC: [date / values]
TSH: [date / value] Lipids: [date / values]
HbA1c: [date / value] Other: [___]
CARDIAC HISTORY: [None / Arrhythmia / QTc prolongation concern / HTN / Other]
// Important for stimulants, antipsychotics, TCAs, lithium
NEUROLOGICAL HISTORY: [None / Seizures / TBI / Migraines / Other]
// Seizure history affects Wellbutrin, clozapine dosing; TBI affects all psychiatric Rx
REPRODUCTIVE HEALTH (if applicable):
PREGNANCY STATUS: [Not pregnant / Pregnant — GA: ___ weeks / Postpartum — ___ weeks]
CONTRACEPTION: [None / Method: ___]
// Critical for valproate, lithium, benzodiazepines, paroxetine counseling
ENDOCRINE: Thyroid: [Normal/Hypothyroid/Hyperthyroid] Diabetes: [Y/N]
HEPATIC/RENAL: [Normal / Impaired — affects medication dosing]
7
Family Psychiatric History
Clinical Value
Family psychiatric history informs diagnostic formulation, helps predict medication response (pharmacogenetics by family history), and identifies genetic risk (e.g., first-degree relative with bipolar disorder increases patient risk ~10x). Ask specifically about suicides — families often don't volunteer this.
Family Psychiatric History
FAMILY PSYCHIATRIC HISTORY:
Relative | Diagnosis | Medication Response / Notes
------------------|------------------------|-------------------------------
Mother | [Depression/Bipolar/etc] | [Responded to sertraline / unknown]
Father | [___] | [___]
Sibling(s) | [___] | [___]
Maternal side | [___] | [___]
Paternal side | [___] | [___]
Children | [___] | [___]
FAMILY HISTORY OF SUICIDE:
[None reported / Yes — Relationship: ___, Method: ___, Patient's age at time: ___]
// Ask directly: "Has anyone in your family died by suicide?"
FAMILY HISTORY OF SUBSTANCE USE DISORDER:
[None / Yes — Relationship: ___, Substance: ___]
FAMILY HISTORY UNKNOWN: [Adopted / Estranged / Unable to obtain]
9
Developmental History
When to Expand
Developmental history is always relevant but especially critical when diagnosing ADHD, autism spectrum disorders, personality disorders, or trauma-related conditions. Abbreviated in routine adult evaluations; expand when clinically indicated.
Developmental History
DEVELOPMENTAL HISTORY:
[ CHILDHOOD ]
Prenatal/birth complications: [None reported / ___]
Developmental milestones: [Met on time / Delayed — specify: ___]
Childhood behavioral issues: [None / ADHD symptoms / Conduct problems / Other]
School performance: [Good / Average / Struggled — retained: Y/N]
Special education services: [None / IEP / 504 — reason: ___]
[ ADVERSE CHILDHOOD EXPERIENCES (ACEs) ]
// Document sensitively — assess for trauma history
Physical abuse: [Denied / Reported]
Sexual abuse: [Denied / Reported / Declined to answer]
Emotional abuse/neglect: [Denied / Reported]
Household dysfunction: [Substance use in home: Y/N | DV: Y/N | Mental illness: Y/N]
ACE Score (if assessed): [___/10]
[ ADOLESCENCE ]
First psychiatric symptoms: [Age: ___]
Behavioral issues: [None / Conduct / Oppositional / Delinquency]
Substance use onset: [Age: ___, Substance: ___]
Sexual development: [Age-appropriate / Concerns: ___]
[ RELATIONSHIPS / ATTACHMENT ]
Primary attachment figure: [___]
Quality of early attachment: [Secure / Insecure — describe: ___]
10
Mental Status Examination
MSE is Your Objective Data
The MSE is the psychiatric equivalent of the physical exam. It is your direct clinical observation — not what the patient reports, but what you observed. Be specific and descriptive. Vague MSEs fail to support complexity billing and are indefensible in malpractice cases.
Mental Status Examination
MENTAL STATUS EXAMINATION:
[ APPEARANCE ]
Age: [Appears stated age / Older / Younger]
Build: [Average / Thin / Overweight / Obese]
Grooming: [Well-groomed / Adequate / Disheveled / Malodorous]
Dress: [Appropriate / Casual / Inappropriate — describe]
Eye contact: [Good / Poor / Avoidant / Intense]
Psychomotor: [No abnormalities / Agitated / Retarded / Tremor / Restless]
[ BEHAVIOR ]
Cooperation: [Cooperative / Guarded / Hostile / Evasive]
Attitude: [Pleasant / Irritable / Suspicious / Seductive / Childlike]
Rapport: [Good / Fair / Difficult to establish]
[ SPEECH ]
Rate: [Normal / Rapid / Slow]
Volume: [Normal / Loud / Soft]
Rhythm: [Normal / Pressured / Halting / Dysarthric]
Fluency: [Fluent / Word-finding difficulty / Other]
Amount: [Normal / Verbose / Terse]
[ MOOD (Subjective) ]
Patient reports: "[In their words — e.g., depressed, anxious, fine, frustrated]"
[ AFFECT (Objective) ]
Quality: [Euthymic / Depressed / Anxious / Irritable / Elevated / Dysphoric / Flat]
Range: [Full / Restricted / Blunted / Flat / Labile]
Intensity: [Normal / Heightened / Diminished]
Appropriateness: [Congruent with thought content / Incongruent — describe]
Mood-affect congruence: [Congruent / Incongruent]
[ THOUGHT PROCESS ]
[Linear, logical, goal-directed]
OR [Circumstantial / Tangential / Loose associations / Flight of ideas /
Thought blocking / Perseveration / Poverty of thought / Disorganized]
[ THOUGHT CONTENT ]
SI: [None / Active — see Risk Assessment]
HI: [None / Active — see Risk Assessment]
Obsessions: [None / Present — content: ___]
Phobias: [None / Present — ___]
Delusions: [None / Present — type: Paranoid / Grandiose / Somatic / Referential]
Content: [___]
Preoccupations: [None / Present — ___]
[ PERCEPTUAL DISTURBANCES ]
Hallucinations: [None]
AH: [None / Present — command: Y/N / content: ___]
VH: [None / Present — ___]
Other: [Tactile / Olfactory / Gustatory / None]
Illusions: [None / Present]
Derealization/Depersonalization: [None / Present]
[ COGNITION ]
Level of consciousness: [Alert / Drowsy / Other]
Orientation: [×4: person, place, time, situation / Disoriented to: ___]
Attention/concentration: [Intact / Impaired — WFST: ___]
Memory — immediate: [Intact / Impaired — digit span: ___]
Memory — short-term: [Intact / Impaired — 3-word recall at 5 min: ___/3]
Memory — long-term: [Intact / Impaired]
Fund of knowledge: [Intact / Limited]
Abstract reasoning: [Intact / Concrete]
Formal cognitive testing: [Not assessed / MoCA: ___/30 / MMSE: ___/30]
[ INSIGHT ]
[Full — acknowledges illness and need for treatment]
[Partial — acknowledges problems but not psychiatric illness]
[Poor — denies illness or need for treatment]
[Absent — no recognition of problems]
[ JUDGMENT ]
[Good — realistic assessment of situations, appropriate decisions]
[Fair — occasional lapses in judgment]
[Poor — consistent poor decision-making, impulsive behavior]
[Impaired — describe: ___]
[ INTELLIGENCE (estimated) ]
[Average / Above average / Below average — based on: vocabulary, history, education]
11
Risk Assessment
⚠ Legal Standard: A thorough, documented risk assessment is your primary protection against malpractice claims related to suicide. Document both the assessment AND your clinical reasoning. A patient dying by suicide after an inadequate risk assessment is a sentinel event. A patient dying after a thorough, documented assessment demonstrating reasonable clinical judgment is a tragedy that you are professionally protected from.
Columbia C-SSRS Framework
The Columbia Suicide Severity Rating Scale (C-SSRS) is used by the FDA, Joint Commission, and is considered the standard of care. This template adapts the C-SSRS framework for documentation while adding HV risk assessment.
Risk Assessment — Columbia C-SSRS Framework
RISK ASSESSMENT:
[ SUICIDAL IDEATION — C-SSRS ]
Current SI: [None / Passive / Active without plan / Active with plan / Active with intent]
If present:
Intensity: [Brief/transient / Intermittent / Persistent]
Frequency: [Rare / Several times/week / Daily]
Duration: [Seconds / Minutes / Hours]
Controllability: [Can control / Cannot control]
Deterrents: [Family / Religion / Fear of pain / None identified]
Reasons: [Reasons for living > dying / Equivocal / Reasons for dying predominate]
Ideation type:
Passive death wish: [Y/N] "I wish I were dead"
Non-specific active SI: [Y/N] "I want to kill myself" without method
SI with method (no plan): [Y/N]
SI with method and plan: [Y/N] Plan: [___]
SI with intent: [Y/N]
SI with intent and plan: [Y/N]
[ SUICIDAL BEHAVIOR — LIFETIME & RECENT ]
Preparatory behaviors (recent 3 months):
[None / Giving away possessions / Researching methods / Obtaining means / Goodbye letters]
Aborted attempt (lifetime): [None / Yes — date: ___, circumstances: ___]
Interrupted attempt (lifetime):[None / Yes]
Actual attempt (lifetime): [None / Yes — number: ___, most lethal: ___]
Most recent attempt: [N/A / Date: ___, Method: ___, Outcome: ___]
[ HOMICIDAL IDEATION ]
HI present: [None]
If present:
Target: [Specific (name: ___) / Non-specific]
Plan: [None / Present: ___]
Means/access: [None / Yes: ___]
Intent: [None / Present]
Action taken: [Duty to warn assessed: Y/N | Tarasoff obligation: Y/N]
[ RISK STRATIFICATION ]
Static risk factors (historical):
[ ] Prior suicide attempt [ ] Chronic psychiatric illness
[ ] Family hx of suicide [ ] History of trauma/abuse
[ ] Chronic pain/physical illness [ ] Male sex assigned at birth
[ ] Age (>45 or adolescent) [ ] LGBTQ+ identity (minority stress)
[ ] Access to firearms [ ] History of impulsivity/violence
Dynamic risk factors (current, modifiable):
[ ] Current SI/plan/intent [ ] Active substance use
[ ] Hopelessness [ ] Recent major loss/stressor
[ ] Recent psychiatric hospitalization [ ] Recent overdose
[ ] Social isolation [ ] Insomnia
[ ] Recent medication change [ ] Treatment non-adherence
[ ] Active psychosis [ ] Ongoing domestic violence
Protective factors:
[ ] Reasons for living [ ] Engaged in treatment
[ ] Future orientation [ ] Strong social support
[ ] Religious/spiritual beliefs [ ] Children at home
[ ] Fear of death/pain [ ] No access to means
[ ] Therapeutic alliance [ ] Problem-solving ability
[ MEANS RESTRICTION COUNSELING ]
Firearms in home: [Y/N] If Y: counseling provided re: securing/removing: [Y/N]
Medication access: [Secured / Unsecured] Limiting quantities discussed: [Y/N]
Other means: [Counseling provided: Y/N]
[ OVERALL RISK LEVEL ]
ACUTE RISK: [Low / Moderate / High / Imminent]
CHRONIC RISK: [Low / Moderate / High]
[ CLINICAL REASONING FOR RISK LEVEL ]
[Patient presents with [risk level] acute risk for self-harm based on:
[List key contributing factors]. Protective factors noted include [list].
Disposition is [outpatient/higher level of care] because [reasoning].
Patient [does/does not) meet criteria for involuntary hold based on [state law, criteria].]
[ SAFETY PLAN ]
Completed: [Y/N — if N, reason: ___]
Warning signs identified: [___]
Internal coping strategies: [___]
Social supports: [Names, phone numbers]
Professional contacts: [Therapist: ___, After-hours line: ___]
Crisis resources provided:
- 988 Suicide & Crisis Lifeline (call or text 988)
- Crisis Text Line: Text HOME to 741741
- Local ER: [Hospital name]
- 911 instructions given: [Y/N]
Safety plan document: [Given to patient / Uploaded to chart]
12
Biopsychosocial Formulation
The Art of Psychiatry
The formulation is where you synthesize all the data into a coherent clinical narrative. It demonstrates clinical reasoning and individualized assessment. A good formulation shows the examiner (and any future provider) WHY you diagnosed what you diagnosed and WHY you're recommending the treatment you're recommending. It also supports high-complexity billing.
Biopsychosocial Formulation
BIOPSYCHOSOCIAL FORMULATION:
[ PREDISPOSING FACTORS ]
Biological: [Genetic loading — FHx of ___; neurobiological vulnerabilities;
medical comorbidities affecting brain: ___]
Psychological: [Attachment style; early trauma; maladaptive schemas;
temperament; cognitive style: ___]
Social: [Adverse childhood experiences; poverty; discrimination;
cultural factors; early relational trauma: ___]
[ PRECIPITATING FACTORS ]
What triggered this episode or this presentation:
[Specific stressors, losses, life events, medication changes, substance use,
medical events — with timeline]
[ PERPETUATING FACTORS ]
What is maintaining the problem:
[Cognitive distortions; avoidance; social isolation; ongoing stressors;
substance use; untreated medical conditions; lack of support: ___]
[ PROTECTIVE FACTORS ]
[Intelligence; motivation for treatment; social support; financial resources;
spirituality; resilience; insight; employment: ___]
[ DIAGNOSTIC SUMMARY ]
[Patient Name] is a [age]-year-old [gender] presenting with a constellation of symptoms
most consistent with [primary diagnosis]. The [duration] course, [characteristic features],
and [ruling out alternatives] support this diagnosis over [differential].
Contributing factors include [predisposing] that created vulnerability, [precipitating]
that triggered the current episode, and [perpetuating] factors that have maintained
symptoms. Treatment prognosis is [good/fair/guarded] given [protective factors]
balanced against [risk factors].
[ DIFFERENTIAL DIAGNOSIS CONSIDERED ]
[Diagnosis 1] — Ruled out because: [___]
[Diagnosis 2] — Ruled out because: [___]
[Diagnosis 3] — Retained for monitoring: [___]
13
DSM-5-TR Diagnoses with ICD-10 Codes
Diagnostic Impression
DIAGNOSES:
[ PSYCHIATRIC — PRIMARY ]
Axis I (DSM-5-TR):
[F32.1] Major Depressive Disorder, moderate, single episode
[F33.1] Major Depressive Disorder, moderate, recurrent
[F41.1] Generalized Anxiety Disorder
[F40.10] Social Anxiety Disorder
[F41.0] Panic Disorder
[F43.10] PTSD
[F31.81] Bipolar II Disorder
[F90.0] ADHD, Predominantly Inattentive
[F20.9] Schizophrenia
[F60.3] Borderline Personality Disorder
// Delete inapplicable codes; add applicable ones
[ SUBSTANCE USE DISORDERS ]
[F10.20] Alcohol Use Disorder, moderate
[F12.20] Cannabis Use Disorder, moderate
[F11.20] Opioid Use Disorder, moderate
[F14.20] Cocaine Use Disorder
[ MEDICAL — RELEVANT ]
[E11.9] Type 2 Diabetes Mellitus
[I10] Essential Hypertension
[E03.9] Hypothyroidism
// List all comorbid medical conditions that affect psychiatric care
[ PSYCHOSOCIAL / Z CODES ]
[Z56.0] Unemployment
[Z63.0] Relationship problems with spouse/partner
[Z62.810] Personal history of physical abuse in childhood
[Z91.19] Non-adherence to medical treatment
[Z87.39] Personal history of other mental/behavioral disorders
ICD-10 Quick Reference
See bottom of page for common ICD-10 codes in outpatient psychiatry. Always use the most specific code available. Unspecified codes (e.g., F32.9) are acceptable initially but should be refined as diagnosis becomes clearer.
14
Treatment Plan
Medication Rationale = Legal Protection
Document why you're prescribing what you're prescribing. FDA-approved vs. off-label, prior trial failures that led here, specific patient factors. This protects you from claims of inappropriate prescribing and supports prior authorizations.
Treatment Plan
TREATMENT PLAN:
[ MEDICATION PLAN ]
// Use the Risk/Benefit format for each medication decision
ACTION: START [Medication] [Dose] [Frequency]
Indication: [Diagnosis] — [FDA-Approved / Off-Label]
Rationale: [Why this medication? Patient-specific factors, prior trial results,
comorbidities, patient preference, formulary considerations]
Risk/Benefit: Discussed risks including [specific side effects relevant to this patient].
Benefits of [symptom relief / functional improvement] outweigh risks.
Patient understood and agreed to proceed. Questions answered.
Monitoring: [What to monitor, when — labs, weight, BP, ECG, etc.]
Instructions: [Take with/without food, timing, titration plan: ___]
ACTION: START [Medication 2] [Dose] [Frequency]
// Repeat for each medication started
[ THERAPY REFERRAL ]
[Not indicated at this time / Referred to: ___]
Modality recommended: [CBT / DBT / CPT / EMDR / Psychodynamic / Supportive / Other]
Rationale: [Why this modality for this patient/diagnosis]
[ ADDITIONAL INTERVENTIONS ]
Labs ordered: [CMP, CBC, TSH, lipids, HbA1c, other: ___]
Referrals: [PCP for ___ / Neurology / Cardiology / Other: ___]
Case management: [Not needed / Social work referral for: ___]
Crisis resources: [988 / Safety plan completed]
Sleep hygiene: [Discussed / Handout provided]
Exercise recommendation: [30 min aerobic 3-5x/week — evidence for depression/anxiety]
Psychoeducation: [Diagnosis education provided re: ___]
Substance use: [SBIRT completed / Referred to: ___]
[ FOLLOW-UP ]
Next appointment: [Date / Timeframe: 2-4 weeks for new medications]
Between-visit contact: [Patient may call ___ with concerns]
Titration instructions: [If tolerated, increase [medication] to [dose] at [timeframe]]
Red flags — when to seek immediate care: [Worsening SI / Manic symptoms /
Severe medication side effects (rash, priapism, serotonin syndrome) /
Psychotic symptoms / New neurological symptoms]
15
Informed Consent Documentation
⚠ Required for Every New Medication
Informed consent is both an ethical and legal requirement. Document specifically what risks were discussed. Generic "risks and benefits discussed" is insufficient. State the specific risks you covered.
Informed Consent Documentation
INFORMED CONSENT:
Informed consent discussion was conducted with [patient / patient and family member: ___].
Patient demonstrated capacity to provide informed consent as evidenced by ability to
understand, appreciate, reason, and communicate treatment decisions.
For each medication prescribed, the following was discussed:
MEDICATION: [Drug name]
Indication & expected benefit: [Why this medication, what it should do]
Common side effects discussed: [List specifically — e.g., nausea, sexual dysfunction,
weight gain, sedation, dry mouth, etc.]
Serious/rare risks discussed: [e.g., Serotonin syndrome with SSRIs; tardive
dyskinesia with antipsychotics; Stevens-Johnson
with lamotrigine; agranulocytosis with clozapine]
FDA Black Box Warning: [Stated if applicable — e.g., suicidality in youth,
increased mortality in elderly with dementia]
Alternative treatments: [Other options presented: ___]
Consequences of not treating: [Discussed: ___]
Drug interactions: [Relevant interactions reviewed: ___]
Pregnancy/reproductive risk: [Discussed if applicable: ___]
Patient acknowledged understanding and agreed to proceed.
Patient's questions: [Answered / No questions]
TREATMENT AGREEMENT:
[Signed treatment agreement obtained / verbal agreement obtained — copy in chart]
Patient understands the following expectations:
- Take medications as prescribed
- Report side effects promptly
- Disclose use of other substances/medications
- Attend scheduled appointments
- Contact office or go to ER if SI develops
DOCUMENTATION OF CAPACITY:
Patient demonstrated [intact / impaired] capacity as evidenced by:
Understanding: [Able to restate diagnosis and treatment plan in own words]
Appreciation: [Understands how treatment applies to own situation]
Reasoning: [Able to weigh pros and cons of options]
Communication: [Expressed clear preference]
16
PDMP Documentation
PDMP Check Documentation
PDMP REVIEW:
Date/time accessed: [MM/DD/YYYY HH:MM]
Database accessed: [State name PDMP — e.g., Florida PDMP / PMP InterConnect]
Patient identity confirmed: [Name, DOB, address matched]
RESULTS:
[ ] No controlled substance prescriptions in the past [90/180] days — consistent with history
[ ] Controlled substances found — consistent with patient-reported medications:
[List: Drug, Dose, Qty, Prescriber, Date, Pharmacy — noting anything notable]
[ ] Unexpected finding identified:
[Describe: multiple prescribers / excessive quantities / dangerous combinations /
drug not reported by patient — and clinical response taken]
CLINICAL RESPONSE TO PDMP:
[No action needed — findings consistent with clinical presentation]
[Clinical conversation conducted regarding: ___]
[Prescribing adjusted based on PDMP findings: ___]
[Referral to addiction specialist due to: ___]
// If controlled substance is being prescribed, this must be completed
// If patient is new, document PDMP check even if no controlled substance prescribed today
17
UDS Ordering Documentation
Urine Drug Screen Documentation
URINE DRUG SCREEN:
ORDERED: [Y — see orders / N — not clinically indicated at this time]
RATIONALE: [New patient baseline / Controlled substance prescribing /
Clinical suspicion / Routine monitoring per treatment agreement]
PANEL: [Standard 10-panel / Extended panel / Specific drugs: ___]
COLLECTION:[In-office observed / Lab send-out / Point-of-care]
// If prior UDS results available:
PRIOR UDS RESULTS:
Date: [___] Results: [Negative / Positive for: ___]
Expected substances present: [Y/N — patient on ___]
Unexpected substances: [None / ___]
Clinical response: [Discussed with patient / No action needed / ___]
18
Billing Complexity Support
Why Document Complexity
CMS E&M guidelines (2021+) use medical decision-making (MDM) OR total time to determine billing level. New patient initial psychiatric evals typically bill 99205 (high complexity) or 99204 (moderate). Document the complexity elements explicitly to support your billed code.
Billing Complexity Statement
BILLING INFORMATION:
CPT CODE: [90791 — Initial psychiatric evaluation / 99205 — New patient, high complexity]
TOTAL TIME: [Total face-to-face time: ## minutes]
// Time-based billing: 90791 = 60-90 min typical; 99205 = 60-74 min
MEDICAL DECISION MAKING (MDM) — for E&M billing:
Problems addressed (supports complexity level):
[ ] New problem — no established management plan (moderate-high)
[ ] New problem with workup required (high)
[ ] Chronic illness with severe exacerbation (high)
[ ] Multiple comorbid psychiatric diagnoses (high)
[ ] Psychiatric illness with medical comorbidities requiring coordination (high)
Data reviewed:
[ ] External records reviewed (prior records, collateral)
[ ] Diagnostic test results reviewed (labs, prior assessments)
[ ] Independent interpretation of diagnostic tests
[ ] Discussed findings with interpreting provider
Risk level:
[ ] Prescription drug management (moderate-high)
[ ] Drug requiring intensive monitoring (high — e.g., clozapine, lithium)
[ ] Diagnosis or treatment significantly limited by social determinants
[ ] Referral for hospital admission or emergency care discussed
[ ] Controlled substance prescription (minimum moderate)
SUPPORTING ELEMENTS DOCUMENTED:
✓ Comprehensive psychiatric history (multi-system review)
✓ Complete mental status examination
✓ Formal risk assessment with stratification
✓ Biopsychosocial formulation
✓ Multiple diagnoses addressed
✓ Medication management with risk/benefit discussion
✓ Safety planning completed
✓ Coordination with other providers (PCP, therapist)
SUPERVISING PHYSICIAN (if applicable):
[Collaborating physician: ___, MD/DO]
[Attestation: Present / Reviewed and agree / Available for consultation]
★
Common ICD-10 Quick Reference
| Code | Diagnosis |
|---|---|
| F32.0 | Major Depressive Disorder, single episode, mild |
| F32.1 | Major Depressive Disorder, single episode, moderate |
| F32.2 | Major Depressive Disorder, single episode, severe without psychosis |
| F33.0 | MDD, recurrent, current episode mild |
| F33.1 | MDD, recurrent, current episode moderate |
| F33.2 | MDD, recurrent, severe without psychosis |
| F41.1 | Generalized Anxiety Disorder |
| F41.0 | Panic Disorder |
| F40.10 | Social Anxiety Disorder, unspecified |
| F43.10 | Post-Traumatic Stress Disorder, unspecified |
| F31.81 | Bipolar II Disorder |
| F31.10 | Bipolar I Disorder, current episode manic, unspecified severity |
| F90.0 | ADHD, Predominantly Inattentive Presentation |
| F90.1 | ADHD, Predominantly Hyperactive-Impulsive |
| F90.2 | ADHD, Combined Presentation |
| F20.9 | Schizophrenia, unspecified |
| F25.9 | Schizoaffective Disorder, unspecified |
| F60.3 | Borderline Personality Disorder |
| F10.20 | Alcohol Use Disorder, moderate |
| F11.20 | Opioid Use Disorder, moderate, uncomplicated |
| F12.20 | Cannabis Use Disorder, moderate |
| F14.20 | Cocaine Use Disorder, moderate, uncomplicated |
| F50.01 | Anorexia Nervosa, restricting type |
| F50.2 | Bulimia Nervosa |
| F51.01 | Primary Insomnia |
| R45.851 | Suicidal ideation |
| T14.91 | Suicide attempt (use with external cause code) |
Social History